ArticleNature communications2026
Cobalt-catalyzed Markovnikov-selective hydrophosphonylation of unactivated alkenes enabled by phthalimidyl phosphite reagents.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Alkene hydrophosphonylation constitutes an indispensable tool for the synthesis of alkylphosphonates which have found widespread applications in pharmaceuticals, agrochemicals and materials science. Although numerous methods for alkene hydrophosphonylation have been reported, achieving Markovnikov selectivity with unactivated alkenes remains a formidable challenge. Herein we report the development of a class of phosphites featuring a unique N-O-P linkage, namely dialkyl phthalimidyl phosphites, which serve as efficient radical trapping reagents. Using dialkyl phthalimidyl phosphites as phosphonylating reagents and diphenylsilane as the hydrogen donor, the cobalt-catalyzed reaction of unactivated alkenes proceeds smoothly at room temperature, delivering exclusively Markovnikov hydrophosphonylation products in satisfactory yields. Notably, the transformation exhibits excellent functional group tolerance, enabling late-stage modification of drug derivatives. A mechanism involving cobalt hydride-mediated hydrogen atom transfer, alkyl radical addition to phosphites, β-scission of phosphoranyl radicals and oxidation of Co
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.